Items where authors include "Ustianowski, A"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 14.

Article

Relph, KA, Russell, CD, Fairfield, CJ et al. (365 more authors) (2022) Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission. Open Forum Infectious Diseases, 9 (5). ofac179.

Rosas, IO, Bräu, N, Waters, M et al. (34 more authors) (2022) Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA). EClinicalMedicine, 47. 101409. ISSN 2589-5370

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Sullivan, MK, Lees, JS, Drake, TM et al. (362 more authors) (2022) Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study : a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, 37 (2). pp. 271-284. ISSN 0931-0509

Niemi, MEK, Karjalainen, J, Liao, RG et al. (3763 more authors) (2021) Mapping the human genetic architecture of COVID-19. Nature, 600 (7889). pp. 472-477. ISSN 0028-0836

Russell, CD, Fairfield, CJ, Drake, TM et al. (369 more authors) (2021) Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study : a multicentre, prospective cohort study. The Lancet Microbe, 2 (8). e354-e365.

Docherty, AB, Mulholland, RH, Lone, NI et al. (377 more authors) (2021) Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. The Lancet Respiratory Medicine, 9 (7). pp. 773-785. ISSN 2213-2600

Drake, TM, Fairfield, CJ, Pius, R et al. (359 more authors) (2021) Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. The Lancet Rheumatology, 3 (7). e498-e506. ISSN 2665-9913

Bloom, CI, Drake, TM, Docherty, AB et al. (340 more authors) (2021) Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 : a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. The Lancet Respiratory Medicine, 9 (7). pp. 699-711. ISSN 2213-2600

Leclerc, QJ, Fuller, NM, Keogh, RH et al. (384 more authors) (2021) Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England. BMC Health Services Research, 21. 566. ISSN 1472-6963

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Rosas, IO, Bräu, N, Waters, M et al. (20 more authors) (2021) Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. New England Journal of Medicine, 384 (16). pp. 1503-1516. ISSN 0028-4793

Gupta, RK, Harrison, EM, Ho, A et al. (372 more authors) (2021) Development and validation of the ISARIC 4C deterioration model for adults hospitalised with COVID-19: a prospective cohort study. The Lancet Respiratory Medicine, 9 (4). pp. 349-359. ISSN 2213-2600

Drake, TM, Docherty, AB, Harrison, EM et al. (398 more authors) (2020) Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study. American Journal of Respiratory and Critical Care Medicine, 202 (12). pp. 1656-1665. ISSN 1073-449X

This list was generated on Sun Jan 22 08:23:52 2023 GMT.